{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:18:55Z","timestamp":1785424735585,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.xphs.2023.03.018","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T01:54:10Z","timestamp":1680573250000},"page":"1975-1984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection"],"prefix":"10.1016","volume":"112","author":[{"given":"Kayoko","family":"Ohura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruko","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2023.03.018_bib0001","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00003495-200363050-00004","article-title":"Intramuscular preparations of antipsychotics - Uses and relevance in clinical practice","volume":"63","author":"Altamura","year":"2003","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.xphs.2023.03.018_bib0002","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1017\/S1092852921000249","article-title":"Long-acting injectable antipsychotics: what, when, and how","volume":"26","author":"Citrome","year":"2021","journal-title":"CNS Spectr"},{"issue":"1","key":"10.1016\/j.xphs.2023.03.018_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0928-0987(94)00070-G","article-title":"The role of the lymphatic-system in the presystemic absorption of fluphenazine after intramuscular administration of fluphenazine decanoate in rats","volume":"3","author":"Huang","year":"1995","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2023.03.018_bib0004","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1012165731390","article-title":"Studies on the mechanism of absorption of depot neuroleptics: Fluphenazine decanoate in sesame oil","volume":"14","author":"Luo","year":"1997","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.xphs.2023.03.018_bib0005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1023\/A:1011978327504","article-title":"The roles of depot injection sites and proximal lymph nodes in the presystemic absorption of fluphenazine decanoate and fluphenazine: Ex vivo experiments in rats","volume":"15","author":"Luo","year":"1998","journal-title":"Pharm Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.03.018_bib0006","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2016.03.064","article-title":"Spatial distribution of oil depots monitored in human muscle using MRI","volume":"505","author":"Kalicharan","year":"2016","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.03.018_bib0007","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijpharm.2017.06.055","article-title":"The contribution of the in-vivo fate of an oil depot to drug absorption","volume":"528","author":"Kalicharan","year":"2017","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.03.018_bib0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2125.1979.tb00941.x","article-title":"Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man","volume":"7","author":"Curry","year":"1979","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2023.03.018_bib0009","article-title":"Fluphenazine decanoate (depot) and enanthate for schizophrenia","author":"Maayan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.xphs.2023.03.018_bib0010","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/jps.23258","article-title":"Species difference of esterase expression and hydrolase activity in plasma","volume":"101","author":"Bahar","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.03.018_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2016.12.010","article-title":"Identification of esterase involved in the metabolism of two corticosteroid soft drugs","volume":"127","author":"Samir","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2023.03.018_bib0012","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/intimm\/dxv012","article-title":"Lymph formation, composition and circulation: a proteomics perspective","volume":"27","author":"Hansen","year":"2015","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.xphs.2023.03.018_bib0013","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2133\/dmpk.21.173","article-title":"Human carboxylesterase isozymes: catalytic properties and rational drug design","volume":"21","author":"Imai","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2023.03.018_bib0014","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.xphs.2023.03.018_bib0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2006.07.001","article-title":"Structure, function and regulation of carboxylesterases","volume":"162","author":"Satoh","year":"2006","journal-title":"Chem Biol Interact"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.03.018_bib0016","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0006-8993(09)90022-1","article-title":"Immunohistochemistry with an antibody to human liver carboxylesterase in human brain tissues","volume":"658","author":"Yamada","year":"1994","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.03.018_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(99)01111-4","article-title":"cDNA cloning, characterization and stable expression of novel human brain carboxylesterase","volume":"458","author":"Mori","year":"1999","journal-title":"FEBS Lett"},{"issue":"12","key":"10.1016\/j.xphs.2023.03.018_bib0018","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.2042-7158.1976.tb04082.x","article-title":"Methods for study of fluphenazine kinetics in man","volume":"28","author":"Whelpton","year":"1976","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"10.1016\/j.xphs.2023.03.018_bib0019","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1248\/cpb.c12-00719","article-title":"Comparison of cytochrome p450 mediated metabolism of three central nervous system acting drugs","volume":"60","author":"Attia","year":"2012","journal-title":"Chem Pharm Bull"},{"issue":"3","key":"10.1016\/j.xphs.2023.03.018_bib0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(25)33233-7","article-title":"Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships","volume":"222","author":"Prozialeck","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.xphs.2023.03.018_bib0021","first-page":"332","article-title":"New fluphenazine analogues as inhibitors of P-glycoprotein in human lymphocyte cultures","volume":"16","author":"Jaszczyszyn","year":"2012","journal-title":"Contemp Oncol"},{"key":"10.1016\/j.xphs.2023.03.018_bib0022","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm00340a002","article-title":"Esters of 4-(3-(2-(trifluoromethyl)phenothiazin-10-Yl)propyl)-1-piperazineuethanol as long-acting tranquilizing agents. synthesis of 4-(3-(2-(trifluoromethyl)-phenothiazin-10-Yl)propyl)-1-piperazineuethanol-ethyl-C14 and its ester with heptanoic acid. 3","volume":"6","author":"Yale","year":"1963","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.xphs.2023.03.018_bib0023","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/jps.24467","article-title":"Design of fexofenadine prodrugs based on tissue-specific esterase activity and their dissimilar recognition by P-glycoprotein","volume":"104","author":"Ohura","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.03.018_bib0024","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"12","key":"10.1016\/j.xphs.2023.03.018_bib0025","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1124\/dmd.116.072736","article-title":"Establishment and characterization of a novel Caco-2 subclone with a similar low expression level of human carboxylesterase 1 to human small intestine","volume":"44","author":"Ohura","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2023.03.018_bib0026","first-page":"159","article-title":"A comparison of theoretical methods of calculation of partition coefficients for selected drugs","volume":"63","author":"Pyka","year":"2006","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.xphs.2023.03.018_bib0027","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejps.2016.07.013","article-title":"Phenothiazines solution complexity - determination of pKa and solubility-pH profiles exhibiting sub-micellar aggregation at 25 and 37\u00b0C","volume":"93","author":"Pobudkowska","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2023.03.018_bib0028","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acs.chemrestox.6b00228","article-title":"Naturally occurring genetic variants of human acetylcholinesterase and butyrylcholinesterase and their potential impact on the risk of toxicity from cholinesterase inhibitors","volume":"29","author":"Lockridge","year":"2016","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"10.1016\/j.xphs.2023.03.018_bib0029","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1432-1033.1979.tb12991.x","article-title":"Characterization of the isoenzymes of pig-liver esterase. 1. Chemical Studies","volume":"95","author":"Heymann","year":"1979","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.xphs.2023.03.018_bib0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.pharmtox.38.1.257","article-title":"The mammalian carboxylesterases: from molecules to functions","volume":"38","author":"Satoh","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.xphs.2023.03.018_bib0031","first-page":"14","article-title":"Purification and substrate specificity of polymorphic forms of esterase D from human erythrocytes","volume":"30","author":"Scott","year":"1978","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.xphs.2023.03.018_bib0032","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejps.2015.07.006","article-title":"Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases","volume":"78","author":"Fukami","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.03.018_bib0033","first-page":"1189","article-title":"Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2","volume":"60","author":"Humerickhouse","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.xphs.2023.03.018_bib0034","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1124\/jpet.106.110577","article-title":"Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol","volume":"319","author":"Tang","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.xphs.2023.03.018_bib0035","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1248\/bpb.20.869","article-title":"Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver","volume":"20","author":"Takai","year":"1997","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"10.1016\/j.xphs.2023.03.018_bib0036","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/jpet.106.111807","article-title":"Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel","volume":"319","author":"Shi","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.xphs.2023.03.018_bib0037","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","article-title":"Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine","volume":"34","author":"Imai","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2023.03.018_bib0038","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0026-895X(24)23159-X","article-title":"An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient","volume":"55","author":"Xie","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"7","key":"10.1016\/j.xphs.2023.03.018_bib0039","first-page":"1458","article-title":"The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase","volume":"59","author":"Morton","year":"1999","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.xphs.2023.03.018_bib0040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.xphs.2019.12.006","article-title":"Effect of calcium on the hydrolysis activity of human butyrylcholinesterase","volume":"109","author":"Imai","year":"2020","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2023.03.018_bib0041","first-page":"67","article-title":"Metabolic fate of fluphenazine decanoate. (1). Absorption, distribution and excretion of 14C-labeled compounds in rats and dogs","volume":"19","author":"Esumi","year":"1991","journal-title":"Jpn Pharmacol Therap"},{"issue":"4","key":"10.1016\/j.xphs.2023.03.018_bib0042","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.1988.tb03091.x","article-title":"Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay","volume":"51","author":"Brimijoin","year":"1988","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.xphs.2023.03.018_bib0043","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1124\/dmd.107.017699","article-title":"Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein","volume":"36","author":"Morimoto","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2023.03.018_bib0044","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0378-4347(96)00287-3","article-title":"Sensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with coulometric detection","volume":"688","author":"Luo","year":"1997","journal-title":"J Chromatogr B"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:41:16Z","timestamp":1758361276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0022354923001181"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.03.018","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}